TY - JOUR T1 - A Microbial Signature Following Bariatric Surgery is Robustly Consistent Across Multiple Cohorts JF - medRxiv DO - 10.1101/2020.11.12.20230581 SP - 2020.11.12.20230581 AU - Farnaz Fouladi AU - Ian M. Carroll AU - Thomas J. Sharpton AU - Emily Bulik-Sullivan AU - Leslie Heinberg AU - Kristine Steffen AU - Anthony A. Fodor Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/16/2020.11.12.20230581.abstract N2 - Background Bariatric surgery induces significant shifts in the gut microbiota which could potentially contribute to weight loss and metabolic benefits. The aim of this study was to characterize a microbial signature following Roux-en-Y Gastric bypass (RYGB) surgery using novel and existing gut microbiota sequence data.Results We generated 16S rRNA gene and metagenomic sequences from fecal samples from patients undergoing RYGB surgery (n = 61 for 16S rRNA gene and n = 135 for metagenomics). We compared these data with three smaller publicly available 16S rRNA gene and one metagenomic datasets from patients who also underwent RYGB surgery. Mixed linear models and machine learning approaches were used to examine the presence of a common microbial signature across studies. Comparison of our new sequences with previous longitudinal studies revealed strikingly similar profiles in both fecal microbiota composition (r = 0.41 ± 0.10; p < 0.05) and metabolic pathways (r = 0.70 ± 0.05; p < 0.001) early after surgery across multiple datasets. Machine learning approaches revealed that the replicable gut microbiota signature associated with RYGB surgery could be used to discriminate pre- and post-surgical samples. Opportunistic pathogen abundance also increased post-surgery in a consistent manner across cohorts.Conclusion Our study reveals a robust microbial signature involving many commensal and pathogenic taxa and metabolic pathways early after RYGB surgery across different studies and sites. Characterization of the effects of this robust microbial signature on outcomes of bariatric surgery could provide insights into the development of microbiome-based interventions for predicting or improving outcomes following surgery.Trial Registration clinicaltrials.gov, number NCT03065426. Registered 27 February 2017, https://www.clinicaltrials.gov/ct2/show/NCT03065426Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03065426Funding StatementThis project was supported by Grant NIH R01 DK112585-01 (PIs: Steffen and Heinberg)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Boards Cleveland Clinic: #16-1460, Sanford Health: #00001409 and North Dakota State University: #PH17112All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequences have been deposited at in the NCBI SRA (National Center for Biotechnology information Sequence Read Archive (https://www.ncbi.nlm.nih.gov/sra) under BiopProject PRJNA668357 and PRJNA668472. Sequences from other datasets that are included in this study can be found at SRA under BioProject PRJNA395660, PRJNA612042, and PRJEB14082, PRJEB12947. Scripts and materials to reproduce all figures and tables are available at https://github.com/FarnazFouladi/RYGB_IntegratedAnalysis2020.RYGBRoux-en-Y Gastric bypassSGSleeve GastrectomyASVsAmplicon Sequence VariantsFDRFalse Discovery RateLASSOLeast Absolute Shrinkage and Selection OperatorAUROCArea Under the Receiver Operating Characteristic CurveLOSOLeave One Study Out (LOSO) ER -